News Quantified

SNY – sanofi - american depositary shares (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Earendil Labs Announces Worldwide Exclusive License Agreement with Sanofi for Next-Generation Bispecific Antibodies for Autoimmune and Inflammatory Bowel Diseases [Yahoo! Finance]

Monument Therapeutics Announces Appointment of Robert Radie as Chair and Heather Preston to Advisory Board [Yahoo! Finance]

Henlius 2025 Global R&D Day: Harnessing the Power of Innovation to Propel Global Strategy to New Heights [Yahoo! Finance]

Sanofi (NASDAQ: SNY) is now covered by analysts at BNP Paribas. They set an "outperform" rating and a $65.00 price target on the stock.

Allergy & Asthma Network and Right2Breathe Partner to Provide Lung Health Screenings at Motorsport Events [Yahoo! Finance]

Form 6-K Sanofi For: Apr 16

Form 6-K Sanofi For: Apr 10

Form 6-K Sanofi For: Apr 04

Form 6-K Sanofi For: Apr 02

Form S-8 Sanofi

Top News Gainers

3/16 Sanofi, Regeneron begin testing arthritis drug as coronavirus treatment [Reuters (UK)] 8.5%

3/13 Algernon Announces Filing of U.S. FDA Pre-IND Meeting Request for Ifenprodil Coronavirus Trial, Expanded Access, and Emergency Use [Canadian Business Journal (Canada)] 8.2%

12/9 Sanofi ends research in diabetes, narrows units to spur profits [Reuters] 7.0%

3/17 Sanofi SA (NYSE: SNY) was upgraded by analysts at Barclays PLC from an "underweight" rating to an "equal weight" rating. 6.5%

4/24 Sanofi confirms targets, strong demand for pain killers lifts first quarter [CNBC] 6.1%

6/6 Runners-Up From Our Sixth Annual Student Editorial Contest [The New York Times] 6.0%

3/3 FDA Approves Sanofi's Multiple Myeloma Drug [The Motley Fool] 5.9%

2/28 UPDATE 1-Sanofi to pay $11.9 mln to resolve U.S. drug charity kickback probe [Reuters] 5.4%

2/6 Sanofi delivers strong 2019 business EPS growth of 6.8% at CER 4.2%

4/13 Reasons for hope: the drugs, tests and tactics that may conquer coronavirus [Reuters] 3.6%

Top News Decliners

3/17 Here are some of the existing drugs that may be repurposed to treat coronavirus [MSNBC.com] -7.7%

3/6 Algernon Announces Availability of its NP-120 Ifenprodil Drug for Compassionate Use for Coronavirus [Canadian Business Journal (Canada)] -6.6%

3/16 Regeneron Is A Phenomenal Growth Story; Buying The Current Dip Could Be A Wise Move [Seeking Alpha] -6.5%

4/14 GlaxoSmithKline CEO calls coronavirus vaccine partnership with Sanofi 'unprecedented collaboration' [CNBC] -4.8%

4/29 GlaxoSmithKline plc (GSK) Q1 2020 Earnings Call Transcript [The Motley Fool] -4.5%

10/31 Sanofi Q3 well on track -4.0%

1/30 Human Insulin Is Available For As Little As $24.88 - But It’s Not For Everyone [Forbes] -3.4%

4/6 Sanofi upsizes debt offerings to €4B; shares up 2% [Seeking Alpha] -3.3%

3/2 Sanofi Pasteur researcher warns against overconfidence with coronavirus vaccine development [CNBC] -3.1%

3/5 Form IRANNOTICE Sanofi -3.0%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day